Aarti Drugs Ltd - AARTI DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE767A01016
₹ 485.75 (-2.01%) icon29 May, 2024, 12:00:00 AM

Aarti Drugs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 5/29/2024 12:00:00 AM

    ₹ 485.75 -9.95 -2.01
  • Open
  • ₹ 493.15
  • Prev. Close
  • ₹ 495.7
  • Turnover(Lac.)
  • ₹ 769
  • Day's High
  • ₹ 497.2
  • Day's Low
  • ₹ 482.35
  • 52 Week's High
  • ₹ 645.75
  • 52 Week's Low
  • ₹ 431.05
  • Book Value
  • ₹ 136.57
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 4,465.74
  • P/E
  • 32.05
  • EPS
  • 15.43
  • Divi. Yield
  • 0.2

Aarti Drugs Ltd Corporate Actions

Aarti Drugs Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Aarti Drugs Ltd SHAREHOLDING SNAPSHOT
29 May , 2024 | 05:31 PM

PROMOTER - TOTAL57.13%

Indian: 57.13%

Foreign: 0%

NON-PROMOTER - TOTAL 42.87%

Institutions: 8.55%

Non-Institutions: 34.31%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Aarti Drugs Ltd FINANCIALS

View Profit & Loss Graph

Aarti Drugs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Aarti Drugs Ltd

  • Prakash M Patil
  • CMD & Executive Director
  • Rashesh C Gogri
  • ED / MD / Promoter
  • Harshit M Savla
  • ED / Joint MD / Promoter
  • Harit P Shah
  • E D & Wholetime Director
  • Uday M Patil
  • WTD & Executive Director
  • Narendra Jagannath Salvi
  • Non Executive Director
  • Navin Chapshi Shah
  • Independent Non Exe. Director
  • Krishnacharya G Akamanchi
  • Independent Non Exe. Director
  • Priti Savla
  • Independent Non Exe. Director
  • Ankit Vikram Paleja
  • Independent Non Exe. Director
  • Bhaskar Narayan Thorat
  • Independent Non Exe. Director
  • Neha Gada
  • Independent Non Exe. Director

Summary

Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million. With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs. It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra. It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary). Of the above subsidiaries, Pinnacle Life Science Private Limited and Aarti Speciality Chemicals Limited are wholly owned subsidiaries.The manufacturing units of the Company are GMP certified. Their products include Active Pharmaceutical Ingredients (APIs), Steroids, Pharmaceutical Intermediates, and Specialty Chemicals, such as Benzene Sulphonyl Chloride, Benzene Sulphonic Acid/ Ammonium/ Sodium Salt and Benzene Sulphonamide. Aarti Drugs Ltd, a part of Aarti Group of Industries, was incorporated in September 28th, 1984. In the year 1993, the company implemented the second phase of their backward integration project and set up facilities for glyoxal (the main raw material for... Read More


Reports by Aarti Drugs Ltd


Reports by Aarti Drugs Ltd

Company FAQ

No Record Found